시장보고서
상품코드
1429309

세계 여드름 치료제 시장 보고서(2024년)

Acne Drugs Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

여드름 치료제 시장 규모는 향후 몇 년동안 꾸준히 성장할 것으로 예상됩니다. 2028년 복합 연간 성장률(CAGR) 4.5%를 나타낼 전망이며 73억 달러로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 경기 확대 가속화, 건강 관리 증가, 신흥국의 큰 잠재력, 10대 인구 증가, 착용하기 쉬운 라이프스타일 확산과 관련될 수 있습니다. 예측 기간 동안 예상되는 주목할만한 동향은 좁은 스펙트럼 항생제에 대한 전략적 투자, 여드름 치료를위한 병용 요법의 제형화, 대마초 제품, 특히 대마유를 포함한 제품에 대한 재정적 헌신, 신약 개발을 위한 파트너십, 여드름 치료 제품 마케팅을 위한 소셜 미디어 플랫폼 활용 등이 포함됩니다.

여드름 치료제 시장은 사람들의 가처분 소득 상승에 크게 영향을 받으며 큰 원동력이되었습니다. 가처분 소득 증가는 보통 경제 개선을 반영하여 임금과 급여가 증가하여 건강 관리 지출이 확대됩니다. 미국 경제분석국에 따르면 개인의 가처분소득은 2023년 7월 73억 달러 급증했습니다. 이 가처분 소득 증가는 페이셜 케어 제품에 대한 지출의 확대와 더불어 앞으로도 계속될 것으로 예상되며, 이에 따라 예측 기간 동안 시장 성장을 가속하게 됩니다.

여드름 유병률의 확대는 예측 가능한 미래에 여드름 치료 시장 성장을 가속하는 주요 원동력이 될 것으로 예측됩니다. 여드름은 유분과 죽은 피부 세포로 인한 모공 막힘으로 인한 피부 질환이며 사람들은 치료법을 찾습니다. 여드름 치료제는 염증을 완화하고, 기름 생성을 줄이고, 모공 막힘을 방지함으로써 기능하며, 마침내 여드름이 생기기 쉬운 피부의 외관을 향상시킵니다. 세계 인구의 거의 90%가 어떤 형태의 여드름에 시달리고 있으며, 이 증상은 광범위한 과제를 일으키고 있습니다. 미국만으로도 약 1,200만 명이 심한 여드름에 시달리고 있으며, 치료하지 않으면 피부에 흉터가 남을 수 있습니다. 그 결과 인구의 상당 부분이 여드름의 상태를 관리하기 위해 여드름 관리 약물과 제품에 투자하고 있습니다. 따라서 여드름의 유병률 증가는 여드름 치료제 시장의 성장을 가속하는 실질적인 추진력이되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나,러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계 시장 규모 실적과 성장(2018년-2023년)
  • 세계 시장 규모 예측과 성장(2023년-2028년, 2033년)

제6장 시장 세분화

  • 세계 여드름 치료제 시장, 유형별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 염증성 여드름 치료제
  • 비염증성 여드름 치료
  • 세계 여드름 치료제 시장, 치료 클래스별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 레티노이드
  • 항생제
  • 살리실산
  • 과산화벤조일
  • 세계 여드름 치료제 시장 : 최종 사용자별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 병원 및 클리닉
  • 약국 및 드럭스토어
  • 외래수술센터(ASC)

제7장 지역 및 국가 분석

  • 세계 여드름 치료제 시장 : 지역별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 세계 여드름 치료제 시장 : 국가별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 여드름 치료제 시장 경쟁 구도
  • 여드름 치료제 시장 기업 프로파일
    • Johnson &Johnson
    • Galderma SA
    • Almirall SA
    • Bausch Health Companies Inc.
    • GlaxoSmithKline

제31장 기타 선도적이고 혁신적인 기업

  • Reckitt Benckiser Group
  • Mayne Pharma Group Limited
  • Allergan Plc.
  • Cipher Pharmaceuticals
  • Sol Gel Advanced Topical Therapy
  • Pfizer Inc.
  • Novartis AG
  • Merck &Co. Inc.
  • Amgen Inc.
  • Abbott
  • AstraZeneca
  • Eli Lilly and Company
  • Daiichi Sankyo Company Limited
  • Sinopharm Group Co. Ltd
  • Mylan NV

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 미래 전망과 가능성 분석

제36장 부록

BJH 24.03.21

Acne medications encompass pharmaceutical solutions designed to address issues related to acne scarring, blackheads, whiteheads, and more severe forms of the condition. These drugs operate by either targeting bacterial infections or reducing edema and oil production. Typically, a timeframe of four to eight weeks is required before prescription acne medications demonstrate efficacy. Complete resolution of acne may extend over several months or even years.

The primary categories of acne drugs include inflammatory and non-inflammatory variants. Inflammatory acne drugs are employed for the treatment of mild to moderate inflammatory acne. Key therapeutic classes comprise retinoids, antibiotics, salicylic acid, and benzoyl peroxide. These medications find application across various end-user segments, including hospitals, clinics, pharmacies, drug stores, and ambulatory surgical centers.

The acne drugs market research report is one of a series of new reports from The Business Research Company that provides acne drugs market statistics, including acne drugs industry global market size, regional shares, competitors with an acne drugs market share, detailed acne drugs market segments, market trends and opportunities, and any further data you may need to thrive in the acne drugs industry. This acne drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acne drugs market size has grown steadily in recent years. It will grow from $5.84 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth observed in the historical period can be ascribed to several factors, including the escalating prevalence of acne, a growing population, robust economic expansion, an upswing in pharmaceutical spending, increased disposable income, and a rise in healthcare expenditure.

The acne drugs market size is expected to see steady growth in the next few years. It will grow to $7.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be linked to accelerated economic expansion, heightened healthcare expenditure, the substantial potential of emerging economies, a rising teenage population, and the prevalence of sedentary lifestyles. Noteworthy trends expected in the forecast period involve strategic investments in narrow-spectrum antibiotics, the formulation of combination therapies for acne treatment, financial commitments in cannabis products, particularly those containing cannabis oil, partnerships for the development of novel drugs, and leveraging social media platforms for the marketing of acne treatment products.

The acne drug market is significantly influenced by the rise in people's disposable income, serving as a major driving force. The escalation in disposable income typically mirrors an improved economy, resulting in augmented wages and salaries, consequently amplifying healthcare spending. According to the Bureau of Economic Analysis, disposable personal income surged by $7.3 billion in July 2023. This upsurge in disposable income, coupled with amplified expenditure on facial care products, is anticipated to persist, thereby fueling market growth during the forecast period.

The escalating prevalence of acne is projected to be a key driver propelling the growth of the acne drug market in the foreseeable future. Acne, a skin condition arising from clogged pores due to oil and dead skin cells, prompts individuals to seek remedies. Acne drugs function by mitigating inflammation, reducing oil production, and preventing pore blockage, ultimately enhancing the appearance of acne-prone skin. With nearly 90% of the global population affected by some form of acne, the condition poses a widespread challenge. In the United States alone, approximately 12 million individuals struggle with severe acne, which, if untreated, can result in skin scarring. Consequently, a significant portion of the population invests in acne care drugs and products to manage the condition. Hence, the mounting prevalence of acne stands as a substantial driver catalyzing growth within the acne drug market.

The latest trend shaping the acne drug market is the adoption of combination therapy, involving the simultaneous use of two drugs with distinct mechanisms of action. Such combinations exhibit enhanced efficacy and improved adherence compared to monotherapy, which involves using a single drug in isolation. This approach combines a topical retinoid drug, effective in unclogging pores, with an antimicrobial drug utilized for treating infections in acne management. Examples of combination therapy include products such as Epiduo, Acanya, Ziana, and Benzamycin, manufactured by Galderma, Allergan, Medicis, and Atrix, respectively.

Leading companies operating in the acne drug market are actively engaged in developing advanced receptor inhibitor drugs and broadening their research into treatment advancements to gain a competitive edge in the burgeoning healthcare sector. Advanced receptor inhibitor drugs function by blocking the activity of specific receptors within the body. For instance, in September 2023, Sun Pharmaceutical Industries Ltd., an India-based biopharmaceutical company, introduced (PR)WINLEVI (clascoterone cream 1% w/w). WINLEVI is formulated to mitigate the effects of acne hormones on the skin by disrupting the androgen cascade, departing from the topical approach in acne treatment that targets follicular hyperkeratinization, inflammation reduction, or antibacterial properties. While the precise mechanism of action of WINLEVI remains under study, it aims to suppress androgen receptor activities within sebaceous gland cells, thereby reducing sebum (oil) production and inflammatory cytokines associated with acne.

In December 2021, the pharmaceutical and healthcare giant Sanofi S.A., headquartered in France and renowned for its expertise in drug development and commercialization, successfully acquired Origimm Biotechnology GmbH for an undisclosed sum. This strategic move by Sanofi aims to bolster its vaccine research and development (R&D) pipeline, enhance its proficiency in skin microbiome and skin immunology, and broaden its array of treatment options for acne. Furthermore, as a result of this acquisition, Sanofi is poised to extend the reach of these innovative products to encompass the entire European market. Origimm Biotechnology GmbH, based in Austria, is a pioneering pharmaceutical company known for its advancements in identifying pathogenic components of the skin microbiome and bacterial antigens responsible for skin diseases.

Major companies operating in the acne drugs market report are Johnson & Johnson, Galderma S.A., Almirall SA, Bausch Health Companies Inc., GlaxoSmithKline, Reckitt Benckiser Group, Mayne Pharma Group Limited, Allergan Plc., Cipher Pharmaceuticals, Sol Gel Advanced Topical Therapy, Pfizer Inc., Novartis AG, Merck & Co. Inc., Amgen Inc., Abbott, AstraZeneca, Eli Lilly and Company, Daiichi Sankyo Company Limited, Sinopharm Group Co. Ltd., Mylan N.V., F. Hoffmann-La Roche Ltd., Bayer AG, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Allergan, Cipla Inc., Zydus Cadila, Otsuka Pharmaceutical Co. Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Jiangsu Hengrui Medicine, Guangzhou Baiyunshan Pharmaceutical, China Meheco Co Ltd., Huadong Medicine Co. Ltd., Pfizer Inc., Galderma S.A., Amgen Europe B.V., Roche Holding AG, Ranbaxy Laboratories, Stiefel Laboratories, BIOCAD, Zentiva (Sanofi), Gedeon Richter PLC, Polpharma SA Pharmaceutical Works, Egis Group, Dermira Inc., Bausch Health Companies Inc., Estee Lauder Inc., Nimue Skincare International.

North America was the largest region in the acne drugs market in 2023. The Middle East is expected to be the largest growing region in the global acne drugs market during the forecast period. The regions covered in the acne drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acne drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The acne drugs market consists of sales of retinoids, antibiotics, and diapsone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acne Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acne drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acne drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acne drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Inflammatory Acne Drugs; Non-Inflammatory Acne Drugs
  • 2) By Therapeutic Class: Retinoids; Antibiotics; Salicylic Acid; Benzoyl Peroxide; Other Therapeutics
  • 3) By End User: Hospitals & Clinics; Pharmacies & Drug Stores; Other End Users
  • Companies Mentioned: Johnson & Johnson; Galderma S.A.; Almirall SA; Bausch Health Companies Inc.; GlaxoSmithKline
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acne Drugs Market Characteristics

3. Acne Drugs Market Trends And Strategies

4. Acne Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Acne Drugs Market Size and Growth

  • 5.1. Global Acne Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Acne Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Acne Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acne Drugs Market Segmentation

  • 6.1. Global Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inflammatory Acne Drugs
  • Non-Inflammatory Acne Drugs
  • 6.2. Global Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retinoids
  • Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
  • 6.3. Global Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Ambulatory Surgical Centers

7. Acne Drugs Market Regional And Country Analysis

  • 7.1. Global Acne Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Acne Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acne Drugs Market

  • 8.1. Asia-Pacific Acne Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acne Drugs Market

  • 9.1. China Acne Drugs Market Overview
  • 9.2. China Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acne Drugs Market

  • 10.1. India Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acne Drugs Market

  • 11.1. Japan Acne Drugs Market Overview
  • 11.2. Japan Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acne Drugs Market

  • 12.1. Australia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acne Drugs Market

  • 13.1. Indonesia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acne Drugs Market

  • 14.1. South Korea Acne Drugs Market Overview
  • 14.2. South Korea Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acne Drugs Market

  • 15.1. Western Europe Acne Drugs Market Overview
  • 15.2. Western Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acne Drugs Market

  • 16.1. UK Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acne Drugs Market

  • 17.1. Germany Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acne Drugs Market

  • 18.1. France Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acne Drugs Market

  • 19.1. Italy Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acne Drugs Market

  • 20.1. Spain Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acne Drugs Market

  • 21.1. Eastern Europe Acne Drugs Market Overview
  • 21.2. Eastern Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acne Drugs Market

  • 22.1. Russia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acne Drugs Market

  • 23.1. North America Acne Drugs Market Overview
  • 23.2. North America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acne Drugs Market

  • 24.1. USA Acne Drugs Market Overview
  • 24.2. USA Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acne Drugs Market

  • 25.1. Canada Acne Drugs Market Overview
  • 25.2. Canada Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acne Drugs Market

  • 26.1. South America Acne Drugs Market Overview
  • 26.2. South America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acne Drugs Market

  • 27.1. Brazil Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acne Drugs Market

  • 28.1. Middle East Acne Drugs Market Overview
  • 28.2. Middle East Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acne Drugs Market

  • 29.1. Africa Acne Drugs Market Overview
  • 29.2. Africa Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acne Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Acne Drugs Market Competitive Landscape
  • 30.2. Acne Drugs Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Galderma S.A.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Almirall SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bausch Health Companies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Acne Drugs Market Other Major And Innovative Companies

  • 31.1. Reckitt Benckiser Group
  • 31.2. Mayne Pharma Group Limited
  • 31.3. Allergan Plc.
  • 31.4. Cipher Pharmaceuticals
  • 31.5. Sol Gel Advanced Topical Therapy
  • 31.6. Pfizer Inc.
  • 31.7. Novartis AG
  • 31.8. Merck & Co. Inc.
  • 31.9. Amgen Inc.
  • 31.10. Abbott
  • 31.11. AstraZeneca
  • 31.12. Eli Lilly and Company
  • 31.13. Daiichi Sankyo Company Limited
  • 31.14. Sinopharm Group Co. Ltd
  • 31.15. Mylan N.V.

32. Global Acne Drugs Market Competitive Benchmarking

33. Global Acne Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acne Drugs Market

35. Acne Drugs Market Future Outlook and Potential Analysis

  • 35.1 Acne Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Acne Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Acne Drugs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제